Andrew Cohen, MD
Radiation Oncology · Las Vegas, NVNPI 1962410274
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,214 of the $4,148 with a category attached, or 77.5%. 37 manufacturers reported payments, led by Palette Life Sciences, Inc. at 30.8% of the total. Reporting peaked in 2023 at $1,970 and has fallen 62.5% since, to $738 in 2025.
Across 86 payments — averaging $48.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$1K
- Novocure Inc.$467
- Regeneron Healthcare Solutions, Inc.$302
- Visionrt, Inc.$199
- AstraZeneca$138
- Bard Peripheral Vascular, Inc.$133
- plus $2K from 31 others
What the payments were for
- Travel & lodging$93323%
- Food & beverage$3,21477%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 6 | $1,275 |
| Novocure Inc. | 6 | $467 |
| Regeneron Healthcare Solutions, Inc. | 6 | $302 |
| Visionrt, Inc. | 1 | $199 |
| AstraZeneca | 2 | $138 |
| Bard Peripheral Vascular, Inc. | 2 | $133 |
| Lantheus Medical Imaging, Inc. | 1 | $131 |
| Novartis | 5 | $103 |
| Gilead | 3 | $94 |
| Genentech USA, Inc. | 4 | $92 |
| Pfizer | 4 | $91 |
| Daiichi Sankyo Inc. | 4 | $90 |
| Sobi, Inc | 3 | $87 |
| Exelixis Inc. | 2 | $87 |
| Ipsen Biopharmaceuticals, Inc | 3 | $70 |
| Merck | 3 | $69 |
| Karyopharm Therapeutics Inc. | 2 | $67 |
| Astellas Pharma US Inc | 3 | $60 |
| AbbVie | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Bayer | 2 | $44 |
| Amgen | 3 | $43 |
| Johnson & Johnson | 2 | $42 |
| Advanced Accelerator Applications | 1 | $40 |
| Telix Pharmaceuticals | 1 | $36 |
| Adaptive Biotechnologies Corporation | 1 | $32 |
| Sanofi | 1 | $32 |
| Tactile Systems Technology Inc | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Bristol Myers Squibb | 1 | $24 |
| GSK | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Puma Biotechnology, Inc. | 1 | $15 |
| Galvanize Therapeutics, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,148 in reported general payments places this provider in the 75th percentile of 47 radiation oncology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alfuzosin Hcl ErAlfuzosin Hcl | 21 | $414 |
| Mometasone Furoate | 16 | $378 |
| Lidocaine Hcl ViscousLidocaine Hcl | 14 | $199 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $109 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Las Vegas
- Farzaneh FarzinLas Vegas$12K
- Samual FrancisLas Vegas$10K
- Ritchie StevensLas Vegas$9K
- Anita PomerantzLas Vegas$9K
- Michael SinopoliLas Vegas$5K
- Raul MeozLas Vegas$3K
- Wei Gang WangLas Vegas$2K
- Robert O LaughlinLas Vegas$2K
- Robert BeckLas Vegas$2K
- Dustin BoyerLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.